We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Promising Phase 2a Data on Prostate Cancer Immunotherapy content piece image
Product News

Promising Phase 2a Data on Prostate Cancer Immunotherapy

Vaccitech Limited and the University of Oxford have announced initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in patients with metastatic castration resistant prostate cancer (mCRPC).
Rapid Coronavirus Testing Kits for Research Use content piece image
Product News

Rapid Coronavirus Testing Kits for Research Use

MicrosensDx has announced a portable coronavirus testing kit for research use that takes less than 25 minutes from taking a sample to test result.
ATCC Partners with Global Scientific Community to Respond to the Coronavirus Pandemic content piece image
Product News

ATCC Partners with Global Scientific Community to Respond to the Coronavirus Pandemic

ATCC has announced it is expanding its support for the U.S. and international research and development communities to respond to the growing coronavirus pandemic.
Automation Solutions and Services to Aid Critical Coronavirus Testing content piece image
Product News

Automation Solutions and Services to Aid Critical Coronavirus Testing

Hamilton Company has announced multiple automation-related initiatives to aid healthcare workers and researchers as they battle the coronavirus (COVID-19) pandemic.
AMSBIO Launch Coronavirus – COVID-19 Research Products content piece image
Product News

AMSBIO Launch Coronavirus – COVID-19 Research Products

AMSBIO have announced the availability of recombinant proteins and antibodies for detection of Coronavirus (COVID-19) and related RNA viruses.
CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection content piece image
Product News

CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection

CEL-SCI Corporation has announced that it is developing an immunotherapy with the potential to treat the COVID-19 coronavirus using its patented LEAPS peptide technology.
Collaborative To Assess Point-of-Care Manufacturing for Cancer Cell Therapies content piece image
Product News

Collaborative To Assess Point-of-Care Manufacturing for Cancer Cell Therapies

Lonza has announced a series of collaborations with leading institutions to exhibit the proprietary Cocoon® Platform’s ability to manufacture novel cell therapies in a decentralized setting.
UK Government Awards Mologic c.£1 million to Develop Rapid Diagnostic Test for COVID-19 content piece image
Product News

UK Government Awards Mologic c.£1 million to Develop Rapid Diagnostic Test for COVID-19

Mologic Ltd has been awarded circa £1 million as part of the UK government’s £46 million international coronavirus (COVID-19) prevention and research funding package.
Combining AI and Automated Discovery Platform To Discover Compounds Against Viruses, Including Coronavirus content piece image
Product News

Combining AI and Automated Discovery Platform To Discover Compounds Against Viruses, Including Coronavirus

Iktos and SRI International (SRI) have announced that the companies have entered into a collaboration agreement designed to accelerate discovery and development of novel anti-viral therapies.
Accelerating Development of Rapid Diagnostic Tests For Ebola content piece image
Product News

Accelerating Development of Rapid Diagnostic Tests For Ebola

Mologic Ltd has announced that it has launched an accelerated program with the Institut Pasteur de Dakar, Senegal to develop a low-cost, high-performance rapid diagnostic test for Ebola.
Advertisement